Trial Summary
What is the purpose of this trial?This study targets individuals in Chicago who have received naloxone administered by first responders within the past week to reverse an overdose, but who have not entered into MAT. Study participants will be recruited through partnerships with the Chicago Fire Department (CFD) and/or Police Department (CPD); first responders will be trained to seek consent from individuals who are alert and oriented after receiving naloxone for future contacts by research staff as part of the naloxone standard protocol. Those who consent will be contacted and screened for study eligibility ideally within one week of naloxone administration; eligible participants will be randomly assigned either to the control group, i.e., referral to MAT as usual, or to Recovery Initiation and Management after Overdose (RIMO), an assertive linkage and recovery support intervention. This intervention builds on an evidence-based intervention for treatment linkage, monitoring, and recovery support evaluated in 3 prior clinical trials by the study team.
Eligibility Criteria
This trial is for adults in Chicago who've had an opioid overdose reversed with naloxone by first responders in the past week, are not currently in treatment, and have a positive screen for Opioid Use Disorder. They must be over 18, able to consent, and speak English.Inclusion Criteria
Screen positive for an Opioid Use Disorder (OUD)
I was revived from an opioid overdose with naloxone by first responders within the last week.
I have not received any treatment in the last 30 days.
Exclusion Criteria
Unable to speak and understand English
Not residing in Chicago
I am unable to understand and give consent for treatment.
+1 more
Participant Groups
The study compares two approaches: usual referral to Medication-Assisted Treatment (MAT) versus Recovery Initiation and Management after Overdose (RIMO), which includes assertive linkage to MAT and ongoing recovery support.
2Treatment groups
Experimental Treatment
Active Control
Group I: Recovery Initiation and Management after Overdose (RIMO)Experimental Treatment2 Interventions
Participants assigned to the RIMO arm will meet with Linkage Managers (LM), who will use motivational interviewing (MI) techniques to: 1) identify the need for treatment and barriers to going, 2) discuss with patients the benefits of their decision to go to treatment, including activities they might enjoy as well as things they do not like about their alcohol/substance use, 3) provide personalized feedback to participants about the status of their condition based on responses to the assessment instruments, 4) help participants resolve ambivalence about their use and move them toward a commitment to change by accessing additional care, 5) address existing barriers to treatment (e.g., childcare, transportation), 6) schedule a treatment appointment, and 7) facilitate medication assisted treatment re-entry and engagement.
Group II: Passive Referral ControlActive Control1 Intervention
Participants will be given information on recently expanded and publicly-funded MAT treatment in their community.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Chestnut Health SystemsChicago, IL
Loading ...
Who Is Running the Clinical Trial?
Chestnut Health SystemsLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator